β-ヒドロキシブチラート脱水素酵素は,NAD+/NADHバランスとミトコンドリアアセチレーションの調節により,臓がん細胞の増殖を促進する

Xiujuan Wei¹, Chengkai Zhang², Xiaoguang Zheng³

¹Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China; Key Laboratory of Laboratory Medicine, Ministry of Education, Zhejiang Provincial Key Laboratory of Medical Genetics, College of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.

The Journal of biological chemistry

|August 30, 2025

まとめ

臓がんではケトン体合成が活発である. 酵素BDH1は,ミトコンドリアアセチレーションとNAD+/NADH比を調節することによって,臓管腺がん (PDAC) 細胞の増殖を促進する.

科学分野:

生物化学
腫瘍学
代謝経路

背景:

ケトン体は炭水化物の欠乏の間,代替エネルギーとして機能する.
ケトン体は代謝や信号伝達などの細胞過程を調節します
癌,特に臓癌におけるケトン体代謝の役割は十分に理解されていません.

研究の目的:

臓がんにおけるケトン体代謝の役割を調査する.
管腺がん (PDAC) 細胞増殖に対する外因的なケトン補給の効果を決定する.
PDACにおけるβ-ヒドロキシブチラート脱水酵素 (BDH1) の発現と機能を調べる.

主な方法:

臓がんにおけるケトン体合成代謝の分析
外因的なケトン補給によるPDAC細胞増殖の評価
PDAC組織と正常組織におけるBDH1発現の定量分析
ミトコンドリアアセチル化とNAD+/NADH比におけるBDH1の役割の調査.

主要な成果:

臓がんではケトン体合成代謝が活性化されます.
外因的なケトンサプリメントはPDAC細胞増殖に影響を与えなかった.
ヒトのPDAC組織では,BDH1の発現が著しく上昇している.
BDH1は,NAD+/NADH比の調節を通じてミトコンドリアのアセチル化を維持することによって,PDAC細胞増殖を促進する.

結論:

ケトンボディの代謝は臓がんの進行に重要な役割を果たします
BDH1は,細胞のNAD+/NADHバランスとPDACにおけるミトコンドリアアセチレーションの重要な調節剤である.
BDH1を標的とした治療は臓がんの治療策となるかもしれません

キーワード:

BDH1 についてケトン体 NAD ((+) /NADH 臓がんミトコンドリアアセチル化

さらに関連する動画

10:11

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue

Published on: January 3, 2013

23.2K

09:35

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

11.3K

関連する概念動画

03:03

mTOR Signaling and Cancer Progression

3.9K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

3.9K

01:46

Electron Transport Chain: Complex I and II

15.0K

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

15.0K

01:15

Pyruvate Oxidation

161.1K

After glycolysis, the charged pyruvate molecules enter the mitochondria via active transport and undergo three enzymatic reactions. These reactions ensure that pyruvate can enter the next metabolic pathway so that energy stored in the pyruvate molecules can be harnessed by the cells.
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...

161.1K

02:53

Adaptive Mechanisms in Cancer Cells

5.9K

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...